Bristol Myers Squibb
NULOJIX
Manufacturer:
Bristol Myers Squibb
Name:
NULOJIX
HCPCS Code Descriptor:
Injection, belatacept, 1 mg
Category:
J Code
HCPCS:
J0485
NDC(s):
00003-0371-13
Primary Type:
Immunosuppressant
Generic/Specialty Status:
Single-Source
Route of Administration:
Intravenous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
NULOJIX is an Immunosuppressant drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The J Code: J0485 is aligned to the drug NULOJIX.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/13
HCPCS Effective Date:
1/1/13
HCPCS Short Description:
Belatacept injection
Billing and Coding Guide:
https://www.bmsaccesssupport.bmscustomerconnect.com/servlet/servlet.FileDownload?file=00P1Y000013YV7lUAG
Patient Assistance:
http://www.bmspaf.org